Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 22 - Number 5



Review Article

Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities

, 22(5): 488 - 504

Muhammad Adnan, Azhar Rasul*, Ghulam Hussain, Muhammad Ajmal Shah*, Iqra Sarfraz, Bushra Nageen, Ammara Riaz, Rida Khalid, Muhammad Asrar, Zeliha Selamoglu, Şevki Adem and Satyajit D. Sarker


DOI: 10.2174/1389450121999201013154542



Review Article

Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches

, 22(5): 505 - 538

Natália F.F. Pirolla, Victor S. Batista, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Caitlin R. McCarthy, Claudio Viegas* and Nailton M. Nascimento-Júnior*


DOI: 10.2174/1389450121999200819144544



Review Article

In Silico Study Examining New Phenylpropanoids Targets with Antidepressant Activity

, 22(5): 539 - 554

Poliane da Silva Calixto, Reinaldo Nóbrega de Almeida, Mirian G.S. Stiebbe Salvadori, Mayara dos Santos Maia, José Maria Barbosa Filho, Marcus Tullius Scotti and Luciana Scotti*


DOI: 10.2174/1389450121666200902171838



Review Article

Antibiotic Potentiation of Natural Products: A Promising Target to Fight Pathogenic Bacteria

, 22(5): 555 - 572

Nabeelah Bibi Sadeer and Mohamad Fawzi Mahomoodally*


DOI: 10.2174/1389450121666200924113740



Review Article

Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation

, 22(5): 573 - 589

A. Harikrishnan, Sunali Khanna and V. Veena*


DOI: 10.2174/1389450121666200804113745



Review Article

To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing Co-crystallized Ligand to Combat HCV

, 22(5): 590 - 604

Heena Tarannum, Bhumika Chauhan, Asmita Samadder, Harekrishna Roy and Sisir Nandi*


DOI: 10.2174/1389450121999200727215020




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

Dec-2021-ban

Related Journals

Related eBooks

eBooks Catalog